Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

ANI Pharma Inc (ANIP)

ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,462,560
  • Shares Outstanding, K 21,774
  • Annual Sales, $ 614,380 K
  • Annual Income, $ -18,520 K
  • EBIT $ 68 M
  • EBITDA $ 150 M
  • 60-Month Beta 0.63
  • Price/Sales 2.35
  • Price/Cash Flow 8.73
  • Price/Book 3.47

Options Overview Details

View History
  • Implied Volatility 44.52% ( -1.08%)
  • Historical Volatility 50.00%
  • IV Percentile 84%
  • IV Rank 72.36%
  • IV High 53.01% on 09/18/24
  • IV Low 22.30% on 05/13/24
  • Put/Call Vol Ratio 1.17
  • Today's Volume 39
  • Volume Avg (30-Day) 90
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 846
  • Open Int (30-Day) 556

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.10
  • Number of Estimates 3
  • High Estimate 1.17
  • Low Estimate 0.99
  • Prior Year 0.95
  • Growth Rate Est. (year over year) +15.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
57.72 +17.64%
on 03/11/25
68.82 -1.34%
on 03/26/25
+13.32 (+24.40%)
since 02/27/25
3-Month
52.74 +28.76%
on 01/13/25
68.82 -1.34%
on 03/26/25
+13.49 (+24.79%)
since 12/27/24
52-Week
52.50 +29.33%
on 12/19/24
70.05 -3.07%
on 03/28/24
-1.79 (-2.57%)
since 03/27/24

Most Recent Stories

More News
5 Top-Ranked Mid-Cap Stocks to Buy for a Stellar Portfolio

Wall Street is suffering from volatility in the first quarter of 2025. Out of the three large-cap indexes, the S&P 500 and the Nasdaq Composite are in negative territory year to date, while the Dow has...

SKYW : 91.75 (-1.68%)
MAT : 19.73 (-0.15%)
CENX : 19.12 (+0.63%)
EAT : 157.05 (+1.89%)
ANIP : 68.19 (+1.52%)
Akebia Stock Drops 28% on Pricing of $50M Common Stock Offering

Akebia Therapeutics AKBA recently announced that it is floating a secondary issue of 25 million shares of its common stock to the public at an issue price of $2 per share, amounting to $50 million.The...

CTMX : 0.6000 (+0.99%)
ETNB : 8.05 (+0.37%)
AKBA : 1.9400 (+1.04%)
ANIP : 68.19 (+1.52%)
Elevation Oncology Plunges 42% on Ending Development of Lead Drug

Shares of Elevation Oncology ELEV plunged more than 40% yesterday after reporting disappointing data from a phase I study on its lead pipeline drug EO-3021 for treating advanced, unresectable or metastatic...

CTMX : 0.6000 (+0.99%)
ETNB : 8.05 (+0.37%)
ELEV : 0.2605 (-0.99%)
ANIP : 68.19 (+1.52%)
ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets

ANIP : 68.19 (+1.52%)
ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®

ANIP : 68.19 (+1.52%)
Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

Q4 Earnings Roundup: Elanco (NYSE:ELAN) And The Rest Of The Pharmaceuticals Segment

ELAN : 10.64 (+0.85%)
JAZZ : 127.25 (-2.77%)
VTRS : 8.78 (-2.01%)
ZTS : 163.46 (+0.39%)
ANIP : 68.19 (+1.52%)
Allogene's Q4 Loss Narrower Than Expected, Revenues Nil

Allogene Therapeutics ALLO incurred a loss of 28 cents per share in fourth-quarter 2024, narrower than the Zacks Consensus Estimate of a loss of 34 cents. In the year-ago period, the company had incurred...

ALLO : 1.5550 (-0.96%)
CTMX : 0.6000 (+0.99%)
ETNB : 8.05 (+0.37%)
ANIP : 68.19 (+1.52%)
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

ANIP : 68.19 (+1.52%)
Relative Price Strength: A Smart Strategy Amid Market Turmoil

The U.S. stock market, after a stellar run in 2023 and 2024, hit a rough patch in early 2025. February saw a sharp pullback, with the S&P 500 tumbling 1.4% and extending losses into March. Investors are...

OOMA : 13.46 (-1.17%)
ANIP : 68.19 (+1.52%)
MATX : 130.43 (-1.86%)
VIRT : 38.38 (-0.42%)
EVER : 28.55 (+2.11%)
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

VTRS : 8.78 (-2.01%)
AMPH : 28.33 (-0.14%)
ANIP : 68.19 (+1.52%)
AMRX : 8.27 (-1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

ANI Pharmaceuticals, Inc. is a specialty pharmaceutical company. It engaged in developing, manufacturing and marketing branded and generic prescription pharmaceuticals. The company offers liquid, powder, oral solid dose, cough/cold products, antacids, laxatives, stomach remedies as well as hydrocortisone...

See More

Key Turning Points

3rd Resistance Point 70.89
2nd Resistance Point 69.86
1st Resistance Point 68.51
Last Price 68.19
1st Support Level 66.13
2nd Support Level 65.10
3rd Support Level 63.75

See More

52-Week High 70.05
Last Price 68.19
Fibonacci 61.8% 63.35
Fibonacci 50% 61.27
Fibonacci 38.2% 59.20
52-Week Low 52.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar